[HTML][HTML] JAK inhibitors and autoimmune rheumatic diseases

M Benucci, P Bernardini, C Coccia, R De Luca… - Autoimmunity …, 2023 - Elsevier
The four Janus kinase (JAK) proteins and the seven Signal Transducers of Activated
Transcription (STAT) mediate intracellular signal transduction downstream of cytokine …

The pre-clinical phase of rheumatoid arthritis: from risk factors to prevention of arthritis

N Petrovská, K Prajzlerová, J Vencovský, L Šenolt… - Autoimmunity …, 2021 - Elsevier
Rheumatoid arthritis (RA) is a chronic autoimmune disease considered as a multistep
process spanning from the interaction of genetic (eg, shared epitope or non-HLA loci) …

[HTML][HTML] Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

F Rivellese, AEA Surace, K Goldmann, E Sciacca… - Nature medicine, 2022 - nature.com
Patients with rheumatoid arthritis (RA) receive highly targeted biologic therapies without
previous knowledge of target expression levels in the diseased tissue. Approximately 40 …

Digital health, big data and smart technologies for the care of patients with systemic autoimmune diseases: where do we stand?

H Bergier, L Duron, C Sordet, L Kawka… - Autoimmunity …, 2021 - Elsevier
The past decade has seen tremendous development in digital health, including in innovative
new technologies such as Electronic Health Records, telemedicine, virtual visits, wearable …

Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications

P Ruscitti, I Di Cola, C Di Muzio, N Italiano, F Ursini… - Autoimmunity …, 2022 - Elsevier
From the introduction of hyperferritinemic syndrome concept, a growing body of evidence
has suggested the role of ferritin as a pathogenic mediator and a relevant clinical feature in …

[HTML][HTML] An update on the biologics for the treatment of antiphospholipid syndrome

Z Yun, L Duan, X Liu, Q Cai, C Li - Frontiers in Immunology, 2023 - frontiersin.org
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombosis and pregnancy morbidity with the persistent presence of antiphospholipid …

Methotrexate in early rheumatoid arthritis: Is the anchor drug still holding?

A Giollo, E Fuzzi, A Doria - Autoimmunity reviews, 2022 - Elsevier
Abstract Treat-to-target (T2T) is currently the most fashionable strategy for treatment-naïve,
early rheumatoid arthritis (RA) patients. A T2T approach can lead to a complete and drug …

[HTML][HTML] Rheumatoid arthritis treatment options and type 2 diabetes: unravelling the association

C Di Muzio, P Cipriani, P Ruscitti - BioDrugs, 2022 - Springer
Multiple lines of evidence have increasingly suggested a pathogenic connection between
rheumatoid arthritis (RA) and the mechanisms of type 2 diabetes (T2D) in a vicious circle …

[HTML][HTML] Personalized medicine and machine learning: A roadmap for the future

M Sebastiani, C Vacchi, A Manfredi… - Journal of Clinical …, 2022 - mdpi.com
In the last ten years, many advances have been made in the treatment and diagnosis of
immune-mediated diseases. In particular, an increasing number of new monoclonal …

Diabetic neuropathy: Pathogenesis and evolving principles of management

B Zaino, R Goel, S Devaragudi, A Prakash… - Disease-a-Month, 2023 - Elsevier
The global rise of prediabetes and diabetes has spawned an epidemic of complications
associated with these conditions. Neuropathy is the most common consequence, with distal …